Picture of PZ Cormay SA logo

CRM PZ Cormay SA Share Price

0.000.00%
pl flag iconLast trade - 00:00
HealthcareAdventurousMicro CapValue Trap

Momentum

Relative Strength (%)
1m-4.64%
3m-18.77%
6m-11.89%
1yr-28.19%
Volume Change (%)
10d/3m+36.03%
Price vs... (%)
52w High-30.95%
50d MA-6.43%
200d MA-10.79%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-8.99%
Return on Equity-7.72%
Operating Margin-6.69%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of PZ Cormay SA EPS forecast chart

Profile Summary

PZ Cormay SA is a Polish-based producer and wholesaler of diagnostic reagents and a distributor of the laboratory equipment. The Company is engaged in the design, manufacture and distribution of a range of products for clinical chemistry, hematology, electrophoresis, parasitology, cytology, coagulation and specific protein recognition. It offers drugs, biochemical rapid tests and devices such as vacuettes and tubes. PZ Cormay SA provides also biochemical analyzers: ACCENT-300, ACCENT-200, PRESTIGE 24i and LIVIA; hematological analyzers: MYTHIC 18, among others, and urinalysis apparatus: IChem 100. On September 1, 2014, Orphee SA acquired 100% stake in TT Management Sp z o o to enable execution of the restructuring plan of Cormay group which aims at transferring production and distribution activity of Cormay group to Orphee SA.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
December 19th, 2006
Public Since
August 20th, 2008
No. of Employees
225
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
pl flag iconWarsaw Stock Exchange
Shares in Issue
84,205,008
Blurred out image of a map
Address
ul. Wiosenna 22, LOMIANKI, 05-092
Web
https://cormay.com/
Phone
+48 227517910
Contact
Blazej Dowgielski
Auditors
Moore Polska Audyt Sp z o.o.

CRM Share Price Performance

Upcoming Events for CRM

Similar to CRM

Picture of CM International SA logo

CM International SA

pl flag iconWarsaw Stock Exchange

Picture of Inventionmed SA logo

Inventionmed SA

pl flag iconWarsaw Stock Exchange

Picture of Massmedica SA logo

Massmedica SA

pl flag iconWarsaw Stock Exchange

Picture of Medicalgorithmics SA logo

Medicalgorithmics SA

pl flag iconWarsaw Stock Exchange

Picture of Medinice SA logo

Medinice SA

pl flag iconWarsaw Stock Exchange

FAQ